Company Filing History:
4 out of 155 
4 out of 63 
2 out of 3,923 
Years Active: 2018-2024
Title: Ulrike Bauder-Wüst: Innovator in Radiopharmaceuticals
Introduction
Ulrike Bauder-Wüst is a prominent inventor based in Schriesheim, Germany. She has made significant contributions to the field of radiopharmaceuticals, particularly in the treatment of prostate cancer. With a total of six patents to her name, her work has advanced the understanding and application of nuclear medicine.
Latest Patents
Her latest patents include the use of labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer. This invention relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents, and for the treatment of various disease states of prostate cancer. The compounds involved are represented by the general Formulae (Ia) or (Ib).
Career Highlights
Ulrike has worked with esteemed institutions such as the Deutsches Krebsforschungszentrum and Ruprecht-Karls-Universität Heidelberg. Her research has been pivotal in developing innovative solutions for cancer treatment, showcasing her dedication to improving patient outcomes.
Collaborations
Some of her notable coworkers include Matthias Eder and Klaus Kopka. Their collaborative efforts have contributed to the advancements in the field of radiopharmaceuticals.
Conclusion
Ulrike Bauder-Wüst's work exemplifies the impact of innovation in medical science, particularly in the fight against prostate cancer. Her contributions continue to influence the development of effective treatments in nuclear medicine.